alexa Winston Patrick Kuo | Harvard University
ISSN: 1948-593X

Journal of Bioanalysis & Biomedicine
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Winston Patrick Kuo

Winston Patrick Kuo Winston Patrick Kuo
Predicine Holdings Ltd

Dr. Kuo received his DDS from Columbia University, his MS from the Harvard/MIT Division of Health Sciences and Technology and his DMSc from Harvard University. Dr. Kuo is the President of Predicine Holdings Ltd, an international organization that is committed to providing healthcare solutions related to precision medicine, development of innovative diagnostics and therapeutics, integrating data analytics. Dr. Kuo has spent over 20 years in academia and 3 years in industry. He was formerly, Chief Operating Officer of the IES Diagnostics that was developing molecular immune diagnostics tests for use in personalized medicine focused on measuring interferons for auto-immune diseases and cancer. Prior to industry, Dr. Kuo was Assistant Professor in the Department of Developmental Biology at Harvard School of Dental Medicine and Director and founder of the Harvard Clinical and Translational Science – Laboratory for Innovative Translational Technologies at Harvard Medical School to provide the Harvard biomedical research community with early access to disruptive and enabling leading edge translational technologies, which was an integral part of the Harvard Catalyst Clinical and Translational Science Center at Harvard Medical School. Dr. Kuo has also been an active member of NIH/SBIR grant review study section for the past 7 years and a peer reviewer for the Qatar National Research Fund for the past 2 years. He sat and advised on the Public-Private-Partnership and Translational CTSA Key Function Committees at the NIH and sits on numerous Scientific Advisory Boards. Dr. Kuo is on the editorial board of several international journals and is Editor-in Chief of the Journal of Circulating Biomarkers and NanoBioMedicine, reviewer of many top-tier journals and has authored over 60 peer-reviewed manuscripts and a few book chapters. He is also founder of the Otto Heinrich Warburg Cancer Research Foundation, focused to foster, fund, and realize biomedical scientific research aimed at advancing knowledge in science and discovering effective and affordable cancer treatments with a focus on cancer metabolism. Prior to leaving Harvard Medical School to industry was the recipient of the prestigious Young Mentor Award.

Research Interest

Oncology, precision medicine, diagnostics, liquid biopsy, therapeutics, big data, translational technologies


The Application of a Novel Nanovolume Capillary Electrophoresis- Based Protein Analysis System in Personalized & Translational Medicine Research

Shu-Bai Liu, Sylvia Sardi, Boldbaatar Sonom, Davide Zocco, Russel McSweeney, Andrew D. Fraser, Allison E. Halleck, Haotian Li, Gary B. Smejkal, Steven Munevar, Jason Gang Jin, Toshi Kawai, Ionita Ghiran, John P. McGrath, Malcolm Whitman, Shu-Wing Ng, and Winston Patrick Kuo

Research Article: J Bioanal Biomed 2013 S3 004

Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version